Option chain shows key data for Flow Beverage's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Flow Beverage.

Flow Beverage (OTC:FLWBF) Stock, Option Chain

Flow Beverage Corp is a health and wellness-focused beverage company at the convergence of three important trends in the consumer-packaged goods industry including, functional ingredients, sustainable packaging and supply chain and premium quality. It markets its premium alkaline spring water in Canada and the United States in original unflavoured and a range of organic flavors in various sizes. The company generates majority of its revenue from sale of packaged water and also provides Co-packing services. Geographically, majority of its revenue is generated from its business in Canada.

SmallCap

Small Cap Analysis

Events

Exclusives

Interview

FLWBF

Flow Beverage will be presenting at the upcoming Benzinga Small-Cap Conference to showcase its operational transformation.

Flow Beverage Corp Optimizes Operations, Eyes Future Growth Amid Economic Shifts

Flow Beverage Corp Could Get A Boost In Path To Profitability As Nonalcoholic Beverage Market Heads For A Summer Rally 

Penny Stocks

Emerging Markets

Markets

COST

SBUX

TSX:FLOW

The National Oceanic and Atmospheric Administration (NOAA) forecasted a hotter-than-normal summer for most of the United States. As Americans look to stay cool and avoid heat exhaustion, sales across the beverage sector are expected to rise.

Flow Beverage Corp Could Get A Boost In Path To Profitability As Nonalcoholic Beverage Market Heads For A Summer Rally

This Sustainable Water Company Is Turning ESG Commitments Into Growth Opportunities

Movers & Shakers

General

Flow Beverage Corp. (OTCQX: FLWBF) (TSX: FLOW) (“Flow”) is a certified B Corp and one of the fastest-growing premium water companies in North America.

FLOW BEVERAGE CRP SUB VTG by Flow Beverage Corp.

Flow Beverage Corp

HC Wainwright &amp; Co. analyst Ed Arce maintains Madrigal Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDGL#NASDAQ">MDGL</a>) with a Buy and raises the price target from $400 to $405.

News

Price Target

Analyst Ratings

MDGL

HC Wainwright & Co. Maintains Buy on Madrigal Pharmaceuticals, Raises Price Target to $405

Warby Parker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRBY#NYSE">WRBY</a>) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.05) by 20 percent. The company reported quarterly sales of $190.64 million which beat the analyst consensus estimate of $187.64 million by 1.60 percent. This is a 17.79 percent increase over sales of $161.85 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

WRBY

Warby Parker Q4 2024 GAAP EPS $(0.06) Misses $(0.05) Estimate

The planned spin-off will result in two separate, publicly traded companies:
<ul>
<li>Costamare Inc. will remain a global container shipping provider, retaining the owned container vessels and Neptune Maritime Leasing Limited businesses.</li>
<li>Costamare Bulkers Holdings Limited will be an international owner and operator of dry bulk vessels and will hold the owned dry bulk vessels and the CBI operating platform.</li>
</ul>

CMRE

Costamare Announced Its Intent To Spin-off The Company's Dry Bulk Business Into A Standalone Company, Costamare Bulkers Holdings Limited

Guidance

NCLH

Norwegian Cruise Line Says Q1 2025 Net Yield Set To Increase ~$0.5% On Constant Currency Basis YoY

Warby Parker Expects FY25 Net Revenue Of $878M - $893M (Est $872.097M), Representing Approximately 14% - 16% Growth YoY

Norwegian Cruise Line Sees FY25 Adj. Net Income ~$1.065B; Sees Adj. EPS ~$2.05 Vs $2.08 Estimate

Full Year 2025 Guidance
For the full year of 2025, excluding any contribution from the recently announced Australian asset acquisition, Civeo expects revenues of $630.0 million to $660.0 million, Adjusted EBITDA of $80.0 million to $90.0 million and capital expenditures of $25.0 million to $30.0 million. This guidance takes into account the recent reduction in currency exchange rates experienced since late 2024.
The Company expects the recently announced Australian asset acquisition to be completed by the end of the second quarter of 2025, subject to regulatory approvals and customary conditions, and we will provide updated 2025 guidance upon completion.

CVEO

Civeo 2025 Outlook: Expects Revenue Of $630M-$660M Vs. $719.51M Est.; Sees Adjusted EBITDA Of $80M-$90M

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Kura Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KURA#NASDAQ">KURA</a>) with a Buy and maintains $40 price target.

Reiteration

KURA

HC Wainwright & Co. Reiterates Buy on Kura Oncology, Maintains $40 Price Target

Life Time Group Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LTH#NYSE">LTH</a>) raises FY2025 sales outlook from $2.91 billion-$2.97 billion to $2.92 billion-$2.98 billion vs $2.93 billion estimate.

Life Time Group Hldgs Raises FY2025 Sales Guidance from $2.91B-$2.97B to $2.92B-$2.98B vs $2.93B Est

Life Time Group Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LTH#NYSE">LTH</a>) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.15 by 80 percent. This is a 42.11 percent increase over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $663.30 million which beat the analyst consensus estimate of $657.76 million by 0.84 percent. This is a 18.69 percent increase over sales of $558.83 million the same period last year.

Life Time Group Hldgs Q4 Adj $0.27 Beats $0.15 Estimate, Sales $663.30M Beat $657.76M Estimate

2025 Outlook
For the full-year 2025, the Company is providing the following outlook:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Total Revenue</td>
<td colspan="1" rowspan="1">$2,575M – $2,650M</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Software and Services Revenue</td>
<td colspan="1" rowspan="1">$1,995M – $2,020M</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Hardware Revenue</td>
<td colspan="1" rowspan="1">$580M – $630M</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">$420M – $445M</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA (%)</td>
<td colspan="1" rowspan="1">16.3% – 16.8%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Non-GAAP Diluted EPS</td>
<td colspan="1" rowspan="1">$0.75 - $0.80</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted Free Cash Flow - Unrestricted1</td>
<td colspan="1" rowspan="1">$170M - $190M</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Conversion (as % of Adjusted EBITDA)</td>
<td colspan="1" rowspan="1">40% - 43%</td>
</tr>
</tbody>
</table>
</figure>

NCR Voyix Expects FY25 Revenue Of $2.575B-$2.650B Vs $2.183B, Adj EPS Of $0.75-$0.80 Vs $0.91 Est

The net purchase price was approximately $124.4 million after credits primarily for contractual lease costs. With this sale of its last remaining property, the Company is also updating the estimated aggregate shareholder liquidating distribution range from an estimated aggregate shareholder liquidating distribution range of $20.00 to $21.00 per common share previously announced on November 15, 2024, to an estimated aggregate shareholder liquidating distribution range of $20.55 to $20.70 per common share, inclusive of the initial liquidating distribution of $19.00 per common share paid by the Company on December 6, 2024.&nbsp;

REIT

Real Estate

Equity Commonwealth Has Closed On The Sale Of Its Last Remaining Property, 1225 Seventeenth Street, A 709,402 Square Foot Office Property In Denver, Colorado, For A Gross Sale Price Of $132.5M

JP Morgan analyst Bill Peterson maintains Joby Aviation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JOBY#NYSE">JOBY</a>) with a Underweight and lowers the price target from $6 to $5.

JOBY

JP Morgan Maintains Underweight on Joby Aviation, Lowers Price Target to $5

International Seaways (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INSW#NYSE">INSW</a>) reported quarterly earnings of $0.72 per share which missed the analyst consensus estimate of $1.24 by 41.94 percent. The company reported quarterly sales of $194.61 million which beat the analyst consensus estimate of $186.16 million by 4.54 percent. This is a 22.38 percent decrease over sales of $250.73 million the same period last year.

INSW

International Seaways Q4 2024 GAAP EPS $0.72 Misses $1.24 Estimate, Sales $194.61M Beat $186.16M Estimate

Warby Parker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRBY#NYSE">WRBY</a>) reported quarterly sales of $190.64 million which beat the analyst consensus estimate of $187.64 million by 1.60 percent. This is a 17.79 percent increase over sales of $161.85 million the same period last year.

Warby Parker Q4 Sales $190.64M Beat $187.64M Estimate

TechnipFMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTI#NYSE">FTI</a>) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.35 by 54.29 percent. This is a 285.71 percent increase over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $2.37 billion which beat the analyst consensus estimate of $2.30 billion by 2.90 percent. This is a 13.91 percent increase over sales of $2.08 billion the same period last year.

TechnipFMC Q4 2024 Adj EPS $0.54 Beats $0.35 Estimate, Sales $2.37B Beat $2.30B Estimate

NCR Voyix Q4 2024 Adj. EPS $0.22 Beats $0.14 Estimate, Sales $682.000M Miss $686.685M Estimate

JP Morgan analyst Doug Anmuth maintains eBay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) with a Neutral and raises the price target from $58 to $60.

EBAY

JP Morgan Maintains Neutral on eBay, Raises Price Target to $60

JP Morgan analyst Pinjalim Bora maintains Nutanix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>) with a Overweight and raises the price target from $83 to $90.

Comments

Flow Beverage

Flow Beverage (FLWBF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga